<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">144</article-id><article-id pub-id-type="doi">10.17650/2313-805X-2018-5-2-24-30</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">VIMENTIN EXPRESSION IN HUMAN CELL LINES OF EPITHELIAL TUMORS</article-title><trans-title-group xml:lang="ru"><trans-title>ЭКСПРЕССИЯ ВИМЕНТИНА В КУЛЬТУРАХ КЛЕТОК ЭПИТЕЛИАЛЬНЫХ ОПУХОЛЕЙ ЧЕЛОВЕКА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7673-4284</contrib-id><name-alternatives><name xml:lang="en"><surname>Bogush</surname><given-names>T. A.</given-names></name><name xml:lang="ru"><surname>Богуши</surname><given-names>Т. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>Татьяна Анатольевна Богуш.</p><p>115478 Москва, Каширское шоссе, 24</p></bio><email>labmedchem@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8701-7707</contrib-id><name-alternatives><name xml:lang="en"><surname>Kaliuzhny</surname><given-names>S. A.</given-names></name><name xml:lang="ru"><surname>Калюжныйм</surname><given-names>С. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8524-2222</contrib-id><name-alternatives><name xml:lang="en"><surname>Chetyrkina</surname><given-names>M. R.</given-names></name><name xml:lang="ru"><surname>Четыркинам</surname><given-names>М. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Leninskie gory, Moscow 119991</p></bio><bio xml:lang="ru"><p>119991 Москва, Ленинские горы, 1, стр. 12</p></bio><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff9"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0405-9360</contrib-id><name-alternatives><name xml:lang="en"><surname>Yastrebova</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Ястребовам</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Leninskie gory, Moscow 119991</p></bio><bio xml:lang="ru"><p>119991 Москва, Ленинские горы, 1, стр. 12</p></bio><xref ref-type="aff" rid="aff8"/><xref ref-type="aff" rid="aff9"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2974-9555</contrib-id><name-alternatives><name xml:lang="en"><surname>Scherbakov</surname><given-names>A. M.</given-names></name><name xml:lang="ru"><surname>Щербаковм</surname><given-names>А. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff7"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6776-4502</contrib-id><name-alternatives><name xml:lang="en"><surname>Mamichev</surname><given-names>I. A.</given-names></name><name xml:lang="ru"><surname>Мамичевм</surname><given-names>И. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff7"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4912-922X</contrib-id><name-alternatives><name xml:lang="en"><surname>Kamensky</surname><given-names>А. А.</given-names></name><name xml:lang="ru"><surname>Каменскийм</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Leninskie gory, Moscow 119991</p></bio><bio xml:lang="ru"><p>119991 Москва, Ленинские горы, 1, стр. 12</p></bio><xref ref-type="aff" rid="aff8"/><xref ref-type="aff" rid="aff9"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">M.V. Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Build. 12</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">M.V. Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Build. 12</institution></aff><aff><institution xml:lang="ru">ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><aff id="aff7"><institution>N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff id="aff8"><institution>M.V. Lomonosov Moscow State University</institution></aff><aff id="aff9"><institution>Build. 12</institution></aff><pub-date date-type="pub" iso-8601-date="2018-05-15" publication-format="electronic"><day>15</day><month>05</month><year>2018</year></pub-date><volume>5</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>24</fpage><lpage>30</lpage><history><date date-type="received" iso-8601-date="2018-07-18"><day>18</day><month>07</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-07-18"><day>18</day><month>07</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Bogush T.A., Kaliuzhny S.A., Chetyrkina M.R., Yastrebova M.A., Scherbakov A.M., Mamichev I.A., Kamensky А.А.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Богуши Т.А., Калюжныйм С.А., Четыркинам М.Р., Ястребовам М.А., Щербаковм А.М., Мамичевм И.А., Каменскийм А.А.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Bogush T.A., Kaliuzhny S.A., Chetyrkina M.R., Yastrebova M.A., Scherbakov A.M., Mamichev I.A., Kamensky А.А.</copyright-holder><copyright-holder xml:lang="ru">Богуши Т.А., Калюжныйм С.А., Четыркинам М.Р., Ястребовам М.А., Щербаковм А.М., Мамичевм И.А., Каменскийм А.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/144">https://umo.abvpress.ru/jour/article/view/144</self-uri><abstract xml:lang="en"><p><bold>Background.</bold> Cell cultures used as a models in studies of epithelial tumors, are obtained not only from solid tumors, but also from extracellular fluids. It is known that dissemination of ovarian cancer in the peritoneum and further growth of tumor cells in ascetic liquid is accompanied with the activation of epithelial-mesenchymal transition, and, therefore, cell cultures derived from extracellular fluids can have a distinct molecular phenotype from primary tumors.</p><p><bold>Objective:</bold> evaluation the “persistence” of epithelial phenotype in breast and ovarian cancer cell cultures.</p><p><bold>Materials and methods.</bold> The cells obtained from pleural fluid (MCF-7, T-47D), colostrum (HBL-100), solid tumors (BT-474, HCC1937) of patients with breast cancer and ascitic fluid (SCOV- 3) of patients with ovarian cancer. The expression of cytokeratins and vimentin was evaluated using a quantitative immunofluorescence method associated with flow cytometry.</p><p><bold>Results.</bold> Vimentin expression in cells derived from extracellular fluids was not changed (line HBL-100), slightly decreased (SCOV-3 cells), or even was lost (MCF-7 and T-47D cells). HCC1937 cells obtained from solid tumor with expected low expression of vimentin acquired a molecular phenotype with a high expression of this mesenchymal marker. In breast cancer cells BT-474 derived from solid tumor a “persistence” of epithelial phenotype was discovered.</p><p><bold>Conclusion.</bold> Quantitative assessment of the de novo expression of mesenchymal protein vimentin showed that the tumor phenotype within the organizm is not always realized in cells adapted to growth in culture, and is not always «strictly» epithelial, and this evidence must be considered with different kinds of molecular studies of epithelial cells in vitro.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>epithelial-to-mesenchymal transition</kwd><kwd>vimentin</kwd><kwd>cell culture</kwd><kwd>breast cancer</kwd><kwd>ovarian cancer</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>эпителиально-мезенхимальный переход</kwd><kwd>виментин</kwd><kwd>клеточная культура</kwd><kwd>рак молочной железы</kwd><kwd>рак яичников</kwd></kwd-group><funding-group><funding-statement xml:lang="en">Russian Foundation for Basic Research (projects No. 18-015-00422, 16-04-00347)</funding-statement><funding-statement xml:lang="ru">Российский фонд фундаментальных исследований (проекты № 18-015-00422, 16-04-00347)</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Davidson B., Holth A., Hellesylt E. et al. The clinical role of epithelial mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions. Hum Pathol 2015;46(1):1–8. DOI: 10.1016/j.humpath.2014.10.004. PMID: 25455994.</mixed-citation><mixed-citation xml:lang="ru">Davidson B., Holth A., Hellesylt E. et al. The clinical role of epithelial mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions. Hum Pathol 2015;46(1):1–8. DOI: 10.1016/j.humpath.2014.10.004. PMID: 25455994.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Choi Y., Lee H. J., Jang M. H. et al. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer. Hum Pathol 2013;44(11):2581–9. DOI: 10.1016/j.humpath.2013.07.003. PMID: 24055090.</mixed-citation><mixed-citation xml:lang="ru">Choi Y., Lee H. J., Jang M. H. et al. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer. Hum Pathol 2013;44(11):2581–9. DOI: 10.1016/j.humpath.2013.07.003. PMID: 24055090.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Heerboth S., Housman G., Leary M. et al. EMT and tumor metastasis. Clin Transl Med 2015;26(4):1–13. DOI: 10.1186/s40169-015-0048-3. PMID: 25852822.</mixed-citation><mixed-citation xml:lang="ru">Heerboth S., Housman G., Leary M. et al. EMT and tumor metastasis. Clin Transl Med 2015;26(4):1–13. DOI: 10.1186/s40169-015-0048-3. PMID: 25852822.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Savagner P., Kusewitt D. F., Carver E. A. et al. Developmental transcription factor slug is required for effective reepithelialization by adult keratinocytes. J Cell Physiol 2005;202(3):858–66. DOI: 10.1002/jcp.20188. PMID: 15389643.</mixed-citation><mixed-citation xml:lang="ru">Savagner P., Kusewitt D. F., Carver E. A. et al. Developmental transcription factor slug is required for effective reepithelialization by adult keratinocytes. J Cell Physiol 2005;202(3):858–66. DOI: 10.1002/jcp.20188. PMID: 15389643.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Thiery J. P., Acloque H., Huang R. Y., Nieto M. A. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139(5):871–90. DOI: 10.1016/j.cell.2009.11.007. PMID: 19945376.</mixed-citation><mixed-citation xml:lang="ru">Thiery J. P., Acloque H., Huang R. Y., Nieto M. A. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139(5):871–90. DOI: 10.1016/j.cell.2009.11.007. PMID: 19945376.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Cao L., Shao M., Schilder J. et al. Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene 2012;31(20):2521–34. DOI: 10.1038/onc.2011.429. PMID: 21963846.</mixed-citation><mixed-citation xml:lang="ru">Cao L., Shao M., Schilder J. et al. Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene 2012;31(20):2521–34. DOI: 10.1038/onc.2011.429. PMID: 21963846.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Wu D. I., Liu L., Ren C. et al. Epithelialmesenchymal interconversions and the regulatory function of the ZEB family during the development and progression of ovarian cancer. Oncol Lett 2016;11(2):1463–8. DOI: 10.3892/ol.2016.4092. PMID: 26893761.</mixed-citation><mixed-citation xml:lang="ru">Wu D. I., Liu L., Ren C. et al. Epithelialmesenchymal interconversions and the regulatory function of the ZEB family during the development and progression of ovarian cancer. Oncol Lett 2016;11(2):1463–8. DOI: 10.3892/ol.2016.4092. PMID: 26893761.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Nieto M. A. Epithelial plasticity: a common theme in embryonic and cancer cells. Science 2013;8(342):1–7. DOI: 10.1126/science.1234850. PMID: 24202173.</mixed-citation><mixed-citation xml:lang="ru">Nieto M. A. Epithelial plasticity: a common theme in embryonic and cancer cells. Science 2013;8(342):1–7. DOI: 10.1126/science.1234850. PMID: 24202173.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Tsai J. H., Donaher J. L., Murphy D. A. et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012;22(6):725–36. DOI: 10.1016/j.ccr.2012.09.022. PMID: 23201165.</mixed-citation><mixed-citation xml:lang="ru">Tsai J. H., Donaher J. L., Murphy D. A. et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012;22(6):725–36. DOI: 10.1016/j.ccr.2012.09.022. PMID: 23201165.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><mixed-citation>Klymenko Y., Kim O., Stack M. S. Complex determinants of epithelial: mesenchymal phenotypic plasticity in ovarian cancer. Cancers (Basel) 2017;9(8):1–32. DOI: 10.3390/cancers9080104. PMID: 28792442.</mixed-citation></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Hay E. D. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005;233(3):706–20. DOI: 10.1002/dvdy.20345. PMID: 15937929.</mixed-citation><mixed-citation xml:lang="ru">Hay E. D. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005;233(3):706–20. DOI: 10.1002/dvdy.20345. PMID: 15937929.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><mixed-citation>Kidd M. E., Shumaker D. K., Ridge K. M. The role of vimentin intermediate filaments in the progression of lung cancer. Am J Respir Cell Mol Biol 2014;50(1):1–6. DOI: 10.1165/rcmb.2013-0314TR. PMID: 23980547.</mixed-citation></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Bogush T. A., Kalyuzhnyy S. A., Dudko E. A. et al. Molecular peculiarities of ascitic ovarian cancer cells revealing by immunofluorescence assay involving flow cytometry. Vestnik Moskovskogo Universiteta. Ser. 2. Khimiya = Moscow State University Bulletin, Ser. 2, Chemistry 2016;57(5):330–5. (In Russ.].</mixed-citation><mixed-citation xml:lang="ru">Богуш Т. А., Калюжный С. А., Дудко Е. А. и др. Молекулярные особенности асцитных клеток рака яичников, выявляемые при иммунофлуоресцентном анализе с привлечением проточной цитофлуориметрии. Вестник Московского университета. Сер. 2. Химия 2016;57(5):330–5.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Bogush T. A., Shaturova A. S., Dudko E. A. et al. Quantitative immunofluorescent estimation of estrogen receptor β expression in human solid tumors using flow cytometry. Vestnik Moskovskogo Universiteta. Ser. 2. Khimiya = Moscow State University Bulletin, Ser. 2, Chemistry 2011;52(4):305–12. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Богуш Т. А., Шатурова А. С., Дудко Е. А. и др. Количественная иммунофлуоресцентная оценка с использованием проточной цитофлуориметрии экспрессии эстрогеновых рецепторов β в солидных опухолях человека. Вестник Московского университета. Сер. 2. Химия 2011;52(4):305–12.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Bai F., Chan H. L., Scott A. et al. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. Cancer Res 2014;74(21):6161–72. DOI: 10.1158/0008–5472.CAN-14-1119. PMID: 25239453. 16.</mixed-citation><mixed-citation xml:lang="ru">15. Bai F., Chan H. L., Scott A. et al. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. Cancer Res 2014;74(21):6161–72. DOI: 10.1158/0008–5472.CAN-14-1119. PMID: 25239453. 16.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><mixed-citation>Strauss R., Li Z. Y., Liu Y. et al. Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One 2011;6(1):1–20. DOI: 10.1371/journal.pone.0016186. PMID: 21264259. 17.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Bezdieniezhnykh N., Lykhova A., Semesiuk N. et al. Establishment and characterization of new breast and ovarian cancer cell lines as a model for studying cellular plasticity in vitro. Exp Oncol 2016;38(2):94–100. PMID: 27356577.</mixed-citation></ref></ref-list></back></article>
